Biodexa Pharmaceuticals Files July 2025 6-K Report
Ticker: BDRX · Form: 6-K · Filed: Jul 31, 2025 · CIK: 1643918
| Field | Detail |
|---|---|
| Company | Biodexa Pharmaceuticals PLC (BDRX) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, routine-filing
TL;DR
Biodexa (formerly Midatech) filed its July 6-K, standard foreign issuer report.
AI Summary
Biodexa Pharmaceuticals PLC filed a Form 6-K on July 31, 2025, reporting for the month of July 2025. The company, formerly known as Midatech Pharma Plc, is based in Cardiff, United Kingdom, and operates in the Pharmaceutical Preparations industry. This filing is a routine report for a foreign private issuer.
Why It Matters
This filing provides routine disclosure for Biodexa Pharmaceuticals PLC as a foreign private issuer, offering transparency to investors about its ongoing reporting obligations.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain specific financial or operational updates that would indicate a change in risk.
Key Players & Entities
- Biodexa Pharmaceuticals PLC (company) — Registrant
- Midatech Pharma Plc (company) — Former company name
- July 2025 (date) — Reporting period
- July 31, 2025 (date) — Filing date
- Cardiff, United Kingdom (location) — Principal executive office
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer either is required to make public in its home country, is required to file with a stock exchange, or has made or will make public.
What was Biodexa Pharmaceuticals PLC formerly known as?
Biodexa Pharmaceuticals PLC was formerly known as Midatech Pharma Plc, with a date of name change on June 2, 2015.
What is the principal executive office address of Biodexa Pharmaceuticals PLC?
The principal executive office is located at 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom.
What is the SIC code for Biodexa Pharmaceuticals PLC?
The Standard Industrial Classification (SIC) code for Biodexa Pharmaceuticals PLC is 2834, which corresponds to Pharmaceutical Preparations.
Does Biodexa Pharmaceuticals PLC file annual reports under Form 20-F or 40-F?
Biodexa Pharmaceuticals PLC indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 31, 2025 regarding Biodexa Pharmaceuticals Plc (BDRX).